Valuation: IRIDEX Corporation

Market Cap 14.31M 12.72M 11.79M 10.73M 20.24M 1.36B 20.56M 142M 55.56M 709M 53.7M 52.56M 2.26B P/E 2026 *
-6.79x
P/E 2027 * -
Enterprise Value 14.31M 12.72M 11.79M 10.73M 20.24M 1.36B 20.56M 142M 55.56M 709M 53.7M 52.56M 2.26B EV / Sales 2026 *
0.27x
EV / Sales 2027 * 0.26x
Free-Float
60.42%
Yield 2026 *
-
Yield 2027 * -
1 day-1.19%
1 week-8.47%
Current month+29.30%
1 month+21.58%
3 months-12.82%
6 months-23.15%
Current year-28.54%
1 week 0.77
Extreme 0.76995
0.95
1 month 0.62
Extreme 0.615
1.02
Current year 0.61
Extreme 0.607
1.65
1 year 0.61
Extreme 0.607
1.65
3 years 0.61
Extreme 0.607
3.65
5 years 0.61
Extreme 0.607
9.46
10 years 0.61
Extreme 0.607
16.39
Manager TitleAgeSince
Chief Executive Officer 54 2024-09-30
Director of Finance/CFO 68 2018-12-17
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 66 2022-03-16
Chairman 77 2010-08-31
Chairman 60 2020-06-23
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Tax

Chief Executive Officer

-23,917 0.1362%
9/16/26 Buy

Chief Financial Officer

7,900 0.0450%
9/14/26 Buy

Chief Financial Officer

2,354 0.0134%
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%-8.47%-21.67%-72.76% 14.31M
-0.93%+4.86%+28.03%+47.67% 255B
-1.06%+4.20%+9.56%+11.84% 161B
-0.27%+0.65%-4.36%+54.87% 151B
+0.57%+3.88%-55.27%-12.46% 64.33B
+1.47%+5.90%-13.25%-12.40% 51.9B
-0.85%+4.81%+9.39%+50.51% 50.25B
-1.70%+1.63%+16.02%+24.23% 49.92B
-1.47%+1.42%+21.88%+59.26% 48.77B
-1.62%+0.73%+30.59%+75.83% 42.93B
Average -0.70%+1.96%+2.09%+22.66% 87.5B
Weighted average by Cap. -0.69%+3.42%+8.51%+35.18%

Financials

2026 *2027 *
Net sales 52.52M 46.69M 43.27M 39.37M 74.29M 4.98B 75.48M 520M 204M 2.6B 197M 193M 8.29B 55.98M 49.76M 46.12M 41.96M 79.18M 5.31B 80.45M 554M 217M 2.77B 210M 206M 8.84B
Net income -2.09M -1.85M -1.72M -1.56M -2.95M -198M -3M -20.66M -8.1M -103M -7.83M -7.66M -329M 1K 888.9 823.89 749.6 1.41K 94.91K 1.44K 9.9K 3.88K 49.53K 3.75K 3.67K 158K
Net Debt - -
Projected Income Statement - Annual - IRIDEX Corporation
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
26-10-16 US$0.8146 -1.19% 42,345
26-10-15 US$0.8245 +0.04% 164,994
26-10-14 US$0.8241 -2.85% 34,069
26-10-13 US$0.8483 -8.69% 185,464
26-10-12 US$0.9290 +4.38% 292,519
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8146USD
Average target price
2.750USD
Spread / Average Target
+237.59%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IRIDEX Corporation
  1. Stock Market
  2. Stocks
  3. IRIX Stock